Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with recommendations for the screening, diagnosis and therapy of breast cancer

• Verfasst von: Wöckel, Achim [VerfasserIn]
• Verfasst von: Sinn, Peter [VerfasserIn]
• Verfasst von: Schneeweiss, Andreas [VerfasserIn]
• Verfasst von: Schütz, Florian [VerfasserIn]
• Titel: Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with recommendations for the screening, diagnosis and therapy of breast cancer
• Paralleltitel: Interdisziplinäre Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms. Leitlinie der DGGG und DKG (S3-Level, AWMF-Registernummer 032/045OL, Dezember 2017) - Teil 1 mit Empfehlungen zur Früherkennung, Diagnostik und Nachsorge des Mammakarzinoms
• Verf.angabe: Achim Wöckel, Jasmin Festl, Tanja Stüber, Katharina Brust, Stephanie Stangl, Peter U. Heuschmann, Ute-Susann Albert, Wilfried Budach, Markus Follmann, Wolfgang Janni, Ina Kopp, Rolf Kreienberg, Thorsten Kühn, Thomas Langer, Monika Nothacker, Anton Scharl, Ingrid Schreer, Hartmut Link, Jutta Engel, Tanja Fehm, Joachim Weis, Anja Welt, Anke Steckelberg, Petra Feyer, Klaus König, Andrea Hahne, Hans H. Kreipe, Wolfram Trudo Knoefel, Michael Denkinger, Sara Brucker, Diana Lüftner, Christian Kubisch, Christina Gerlach, Annette Lebeau, Friederike Siedentopf, Cordula Petersen, Hans Helge Bartsch, Rüdiger Schulz-Wendtland,Markus Hahn, Volker Hanf, Markus Müller-Schimpfle, Ulla Henscher, Renza Roncarati, Alexander Katalinic, Christoph Heitmann, Christoph Honegger, Kerstin Paradies, Vesna Bjelic-Radisic, Friedrich Degenhardt, Frederik Wenz, Oliver Rick, Dieter Hölzel, Matthias Zaiss, Gudrun Kemper, Volker Budach, Carsten Denkert, Bernd Gerber, Hans Tesch, Susanne Hirsmüller, Hans-Peter Sinn, Jürgen Dunst, Karsten Münstedt, Ulrich Bick, Eva Fallenberg, Reina Tholen, Roswita Hung, Freerk Baumann, Matthias W. Beckmann, Jens Blohmer, Peter A. Fasching, Michael P. Lux, Nadia Harbeck, Peyman Hadji, Hans Hauner, Sylvia Heywang-Köbrunner, Jens Huober, Jutta Hübner, Christian Jackisch, Sibylle Loibl, Hans-Jürgen Lück, Gunter von Minckwitz, Volker Möbus, Volkmar Müller, Ute Nöthlings, Marcus Schmidt, Rita Schmutzler, Andreas Schneeweiss, Florian Schütz, Elmar Stickeler, Christoph Thomssen, Michael Untch, Simone Wesselmann, Arno Bücker, Mathias Krockenberger
• E-Jahr: 2018
• Jahr: 19. Oktober 2018
• Umfang: 22 S.
• Fussnoten: Gesehen am 02.04.2020
• Titel Quelle: Enthalten in: Geburtshilfe und Frauenheilkunde
• Ort Quelle: Stuttgart : Thieme, 1980
• Jahr Quelle: 2018
• Band/Heft Quelle: 78(2018), 10, Seite 927-948
• ISSN Quelle: 1438-8804
• DOI: doi:10.1055/a-0646-4522
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1693834987

Abstract

Purpose: The aim of this official guideline coordinated and published by the German Society for Gynecology and Obstetrics (DGGG) and the German Cancer Society (DKG) was to optimize the screening, diagnosis, therapy and follow-up care of breast cancer. Methods: The process of updating the S3 guideline dating from 2012 was based on the adaptation of identified source guidelines which were combined with reviews of evidence compiled using PICO (Patients/Interventions/Control/Outcome) questions and the results of a systematic search of literature databases and the selection and evaluation of the identified literature. The interdisciplinary working groups took the identified materials as their starting point to develop recommendations and statements which were modified and graded in a structured consensus procedure. Recommendations: Part 1 of this short version of the guideline presents recommendations for the screening, diagnosis and follow-up care of breast cancer. The importance of mammography for screening is confirmed in this updated version of the guideline and forms the basis for all screening. In addition to the conventional methods used to diagnose breast cancer, computed tomography (CT) is recommended for staging in women with a higher risk of recurrence. The follow-up concept includes suggested intervals between physical, ultrasound and mammography examinations, additional high-tech diagnostic procedures, and the determination of tumor markers for the evaluation of metastatic disease.